letters & comments

NHC Comments on CMS 2026 Notice of Benefit and Payment Parameters

11/12/2024 Read More

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

09/26/2024 Read More

NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule Medicare and Medicaid Programs: Calendar Year 2025 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies

09/09/2024 Read More

NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the CY 2025 OPPS proposed rule

09/09/2024 Read More

NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms

09/03/2024 Read More

NHC Comments on Framework for Discussion on Reforming the NIH

08/16/2024 Read More

NHC Comments on Request for Information (RFI) on the future of 21st Century Cures 2.0 legislation

08/02/2024 Read More

NHC Comments on National Institutes of Health (NIH) Office of Science Policy (OSP): Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning

07/22/2024 Read More

NHC Comments on the Federal Evidence Agenda on Disability Equity

07/15/2024 Read More
« Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19